[ad_1] SHANGHAI, Dec. 8, 2025 /PRNewswire/ — AsymBio, a technology-driven global Contract Development and Manufacturing Organization (CDMO) and a subsidiary of Asymchem Group (stock code: 002821.SZ / 6821.HK), today announced the official start of commercial […]
